Quarterly ResultAug 5, 2026, 06:37 AM
LeMaitre Vascular Q2 Net Sales +9.6% to $70.4M; EPS $0.74
AI Summary
LeMaitre Vascular reported strong financial results for the second quarter and first half of 2026. Net sales for Q2 increased 9.6% to $70.4 million, while net income surged 23.7% to $17.1 million, leading to a diluted EPS of $0.74. For the first six months, net sales grew 10.3% to $136.9 million and net income climbed 32.0% to $32.7 million. The company also declared a quarterly cash dividend of $0.25 per share, a 25% increase from the prior year, and adjusted its convertible senior notes conversion rate accordingly.
Key Highlights
- Q2 2026 Net Sales increased 9.6% to $70.4 million from $64.2 million in Q2 2025.
- Q2 2026 Net Income rose 23.7% to $17.1 million from $13.8 million in Q2 2025.
- Q2 2026 Diluted EPS was $0.74, a 23.3% increase from $0.60 in Q2 2025.
- H1 2026 Net Sales grew 10.3% to $136.9 million from $124.1 million in H1 2025.
- H1 2026 Net Income increased 32.0% to $32.7 million from $24.8 million in H1 2025.
- Quarterly cash dividend declared was $0.25 per share, up from $0.20 in Q2 2025.
- Net cash provided by operating activities for H1 2026 was $31.1 million, up 5.9% YoY.
- Convertible senior notes conversion rate adjusted to 8.3820 shares due to increased dividend.
Price Impact
More from LMAT